JNJ
Johnson & Johnson
October 22, 2026 · intraday
- Rarity
- 1.42
- Peak move
- +4.36%
- Float cap
- $619.7B
Still running — rarity and peak move can only rise from here.
Johnson & Johnson is a global healthcare company operating in two segments: Innovative Medicine, which develops prescription drugs for oncology, immunology, neuroscience, cardiovascular and infectious disease, and MedTech, which sells surgical, orthopedic, cardiovascular and vision products. Its customers are hospitals, physicians, clinics, wholesalers and retailers, with roughly half of revenue from the United States. The consumer brands were spun off as Kenvue in 2023.
Where do you see this going?
no votes yetVote to see the split.
What we found
no events · 0 from SEC or newswire · 0 timed with the moveNothing found.We searched SEC filings, the newswires and the open web across the three days around this move and found no public information that explains it.